Literature DB >> 20970502

Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells.

Alberto Bosque1, Vicente Planelles.   

Abstract

HIV-1 latency is considered the last hurdle toward viral eradication in the presence of antiretroviral therapy. Studies of viral latency in vivo are complicated by the low frequency of latently infected cells found in HIV-1 patients. To be able to study the signaling pathways and viral determinants of latency and reactivation, we have developed a novel method that generates high numbers of latently HIV-1 infected cells, which are derived from human primary CD4(+) T lymphocytes. This method allows for the study of different aspects of HIV-1 latency, such as the transcription factors needed for viral reactivation and the signaling pathways involved. In this review, we describe in detail an experimental protocol for the generation of HIV-1 latency using human primary CD4(+) T cells. We also present the salient points of other latency models in the field, along with key findings arising from each model. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20970502      PMCID: PMC3031099          DOI: 10.1016/j.ymeth.2010.10.002

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  50 in total

1.  CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.

Authors:  R Förster; A Schubel; D Breitfeld; E Kremmer; I Renner-Müller; E Wolf; M Lipp
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

2.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes.

Authors:  Gautam K Sahu; Kyeongeun Lee; Jiaxiang Ji; Vivian Braciale; Samuel Baron; Miles W Cloyd
Journal:  Virology       Date:  2006-08-17       Impact factor: 3.616

4.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

Authors:  D Finzi; M Hermankova; T Pierson; L M Carruth; C Buck; R E Chaisson; T C Quinn; K Chadwick; J Margolick; R Brookmeyer; J Gallant; M Markowitz; D D Ho; D D Richman; R F Siliciano
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

5.  Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals.

Authors:  M A Ostrowski; T W Chun; S J Justement; I Motola; M A Spinelli; J Adelsberger; L A Ehler; S B Mizell; C W Hallahan; A S Fauci
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line.

Authors:  S Emiliani; W Fischle; M Ott; C Van Lint; C A Amella; E Verdin
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.

Authors:  Samuel A Williams; Lin-Feng Chen; Hakju Kwon; Carmen M Ruiz-Jarabo; Eric Verdin; Warner C Greene
Journal:  EMBO J       Date:  2005-12-01       Impact factor: 11.598

8.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

9.  Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein.

Authors:  P M Challita-Eid; E Klimatcheva; B T Day; T Evans; K Dreyer; B J Rimel; J D Rosenblatt; V Planelles
Journal:  AIDS Res Hum Retroviruses       Date:  1998-12-20       Impact factor: 2.205

10.  HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.

Authors:  Joshua L Andersen; Jason L DeHart; Erik S Zimmerman; Orly Ardon; Baek Kim; Guillaume Jacquot; Serge Benichou; Vicente Planelles
Journal:  PLoS Pathog       Date:  2006-12       Impact factor: 6.823

View more
  64 in total

1.  Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.

Authors:  Frank Wolschendorf; Alberto Bosque; Takao Shishido; Alexandra Duverger; Jennifer Jones; Vicente Planelles; Olaf Kutsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  HIV Tat controls RNA Polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells.

Authors:  Jonathan E Reeder; Youn-Tae Kwak; Ryan P McNamara; Christian V Forst; Iván D'Orso
Journal:  Elife       Date:  2015-10-21       Impact factor: 8.140

Review 3.  HIV reservoirs and latency models.

Authors:  Matthew J Pace; Luis Agosto; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

4.  HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay.

Authors:  Sara Sunshine; Rory Kirchner; Sami S Amr; Leandra Mansur; Rimma Shakhbatyan; Michelle Kim; Alberto Bosque; Robert F Siliciano; Vicente Planelles; Oliver Hofmann; Shannan Ho Sui; Jonathan Z Li
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

5.  SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.

Authors:  Jenna M Antonucci; Sun Hee Kim; Corine St Gelais; Serena Bonifati; Tai-Wei Li; Olga Buzovetsky; Kirsten M Knecht; Alice A Duchon; Yong Xiong; Karin Musier-Forsyth; Li Wu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 6.  Translational challenges in targeting latent HIV infection and the CNS reservoir problem.

Authors:  Carolina Garrido; David M Margolis
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

7.  H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells.

Authors:  Manoj K Tripathy; Mary E M McManamy; Brandon D Burch; Nancie M Archin; David M Margolis
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

8.  HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.

Authors:  Michael A Moso; Jenny L Anderson; Samantha Adikari; Lachlan R Gray; Georges Khoury; Judy J Chang; Jonathan C Jacobson; Anne M Ellett; Wan-Jung Cheng; Suha Saleh; John J Zaunders; Damian F J Purcell; Paul U Cameron; Melissa J Churchill; Sharon R Lewin; Hao K Lu
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

9.  Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.

Authors:  Laura J Martins; Pawel Bonczkowski; Adam M Spivak; Ward De Spiegelaere; Camille L Novis; Ana Beatriz DePaula-Silva; Eva Malatinkova; Wim Trypsteen; Alberto Bosque; Linos Vanderkerckhove; Vicente Planelles
Journal:  AIDS Res Hum Retroviruses       Date:  2015-07-14       Impact factor: 2.205

10.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.